within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AB05_Rifapentine;

model Rifapentine
  extends Pharmacolibrary.Drugs.ATC.J.J04AB05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J04AB05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Rifapentine is a long-acting rifamycin antibiotic used primarily in the treatment of tuberculosis (TB), including latent TB infection and active pulmonary TB. It acts by inhibiting DNA-dependent RNA polymerase in Mycobacterium tuberculosis. Rifapentine is approved by several regulatory agencies including the FDA and is commonly used in combination regimens with other anti-tuberculous agents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects, both male and female, following oral administration.</p><h4>References</h4><ol><li><p>MacDougall, C, et al., &amp; Louie, J (2022). Systematic review of drug-drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management. <i>Pharmacotherapy</i> 42(4) 343–361. DOI:<a href=&quot;https://doi.org/10.1002/phar.2672&quot;>10.1002/phar.2672</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35152432/&quot;>https://pubmed.ncbi.nlm.nih.gov/35152432</a></p></li><li><p>Marshall, JD, et al., &amp; Kearns, GL (1999). Rifapentine pharmacokinetics in adolescents. <i>The Pediatric infectious disease journal</i> 18(10) 882–888. DOI:<a href=&quot;https://doi.org/10.1097/00006454-199910000-00009&quot;>10.1097/00006454-199910000-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10530584/&quot;>https://pubmed.ncbi.nlm.nih.gov/10530584</a></p></li><li><p>Blake, MJ, et al., &amp; Kearns, GL (2006). Pharmacokinetics of rifapentine in children. <i>The Pediatric infectious disease journal</i> 25(5) 405–409. DOI:<a href=&quot;https://doi.org/10.1097/01.inf.0000214963.55217.9c&quot;>10.1097/01.inf.0000214963.55217.9c</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16645503/&quot;>https://pubmed.ncbi.nlm.nih.gov/16645503</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Rifapentine;
